Key points
- The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.
- These recommendations become official CDC policy once adopted by CDC's Director.
- Learn about current and historical ACIP recommendations for Influenza (flu) vaccine.
Published in the Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
ARCHIVED Influenza Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR; August 25, 2023;72(RR-2);1-25
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season
Print version See page 1. - See also:
- MMWR; August 26, 2022;70(RR-1);1-28
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
Print version See page 1. - See also:
- MMWR; August 27, 2021;70(RR-5);1-28
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2021-22 Influenza Season
Print version See page 1. - See also:
- MMWR; August 21, 2020;69(RR-8);1-24
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020-21 Influenza Season
Print version See page 1. - See also:
- MMWR; August 23, 2019;68(RR-3);1-21
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
Print version See page 1. - See also:
- MMWR; August 24, 2018;67(RR-3);1-20
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season
Print version See page 1. - See also:
- MMWR; June 8, 2018;67(22);643-5
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
Print version See page 1. - MMWR; August 25, 2017;66(RR-2);1-20
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
Print version See page 1. - See also:
- MMWR; August 26, 2016;65(RR-5);1-54
Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices — United States, 2016–17 Influenza Season
Print version See page 26. - See also:
- MMWR; August 7, 2015;64(30);818-825
Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP – U.S., 2015-16 Influenza Season
Print version See page 10. - MMWR; August 15, 2014 / 63(32);691-697
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP – U.S., 2014-15 Influenza Season
Print version See page 11. - MMWR; September 20, 2013 / 62(RR07);1-43
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP — United States, 2013-2014
Print version See page 1.- Summary of the 2013-2014 Recommendations:
Summary Recommendations: Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP—United States, 2013-14
- Summary of the 2013-2014 Recommendations:
- MMWR, May 10, 2013 / 62(18);356-356
Prevention and Control of Influenza with Vaccines: Interim Recommendations of ACIP, 2013
Print version See page 12. - MMWR, August 17, 2012 / 61(32);613-618
Prevention and Control of Influenza with Vaccines: Recommendations of ACIP — United States, 2012-13 Influenza Season
Print version See page 9. - MMWR, August 26, 2011 / 60(33);1128-1132
Prevention and Control of Influenza with Vaccines: Recommendations of ACIP, 2011
Print version See page 12. - MMWR, January 21, 2011, / 60(RR01);1-24
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza: Recommendations of ACIP
Print version See page 1. - MMWR, August 13, 2010, Vol 59(31);989-992
Update: Recommendations of ACIP Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
Print version See page 17. - MMWR, August 6, 2010 / 59(RR08);1-62
Prevention and Control of Influenza with Vaccines: Recommendations of ACIP, 2010
Print version See page 1. - MMWR, April 30, 2010 / 59(16);485-486
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged 65 Years or Older (Fluzone High-Dose) and Guidance for Use — United States, 2010
Print version See page 9. - MMWR, August 28, 2009 / 58(RR10);1-8
Use of Influenza A (H1N1) 2009 Monovalent Vaccine
Print version See page 1. - MMWR, July 31, 2009 / 58(RR08);1-52
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of ACIP, 2009
Print version See page 9. - MMWR, November 23, 2007 / 56(46);1217-1219
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist®) to Children Aged 2-4 Years and Other FluMist Changes for the 2007-08 Influenza Season
Print version See page 9. - MMWR, February 24, 2006 / 55(RR-2);
Influenza Vaccination of Health-Care Personnel
Print version See page 18.